Amyotrophic lateral sclerosis: recent advances and future therapies

Area of Science:

• Neuroscience
• Pharmacology
• Biotechnology

Background:

• Amyotrophic lateral sclerosis (ALS) is a rare, fatal motor neuron disease.
• Current treatments, like riluzole, offer limited survival benefits.
• Intensive research is ongoing to find disease-modifying therapies for ALS.

Purpose of the Study:

• To review recent advances in the search for disease-modifying therapies for ALS.
• To highlight novel therapeutic strategies and their potential impact.

Main Methods:

• Review of established and novel therapeutic agents.
• Investigation of growth factor delivery systems.
• Exploration of non-drug-based therapies like gene silencing and stem cells.

Main Results:

• Re-evaluation of existing drugs (e.g., beta-lactam antibiotics, minocycline) for neuroprotection.
• Development of growth factor delivery systems for CNS treatment.
• Identification of heat-shock protein co-inducers for neuroprotection.
• Progress in gene-silencing and stem cell therapies for ALS.

Conclusions:

• Significant progress in understanding ALS pathogenesis and developing new treatments.
• Need for clinically relevant preclinical studies and improved clinical trial design.
• Hope for effective disease-modifying treatments through validated preclinical therapeutics.